- Home
- CNTA vs ATAT Comparison
CNTA vs ATAT Comparison
Compare CNTA & ATAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | ATAT |
|---|---|---|
| Founded | 2020 | 2013 |
| Country | United Kingdom | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.1B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CNTA | ATAT |
|---|---|---|
| Price | $39.50 | $37.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $43.17 | ★ $49.00 |
| AVG Volume (30 Days) | ★ 4.9M | 1.1M |
| Earning Date | 05-13-2026 | 05-21-2026 |
| Dividend Yield | N/A | ★ 2.12% |
| EPS Growth | ★ 29.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,000,000.00 | N/A |
| Revenue This Year | N/A | $25.48 |
| Revenue Next Year | N/A | $18.11 |
| P/E Ratio | ★ N/A | $26.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.95 | $23.99 |
| 52 Week High | $40.26 | $43.17 |
Technical Indicators
Market Signals| Indicator | CNTA | ATAT |
|---|---|---|
| Relative Strength Index (RSI) | 73.71 | 49.20 |
| Support Level | $39.16 | $36.73 |
| Resistance Level | $40.26 | $38.76 |
| Average True Range (ATR) | 0.22 | 1.34 |
| MACD | -0.45 | 0.04 |
| Stochastic Oscillator | 52.34 | 29.81 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
About ATAT Atour Lifestyle Holdings Limited
Atour Lifestyle Holdings Ltd is an upper-midscale hotel chain in China. The company derives revenues from franchise and management fees from its manachised hotels and sales of hotel supplies to manachised hotels, Operations of leased hotels, and sales of retail products. The company has one operating segment, which is the Atour Group.